BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 34769808)

  • 1. Occurrence, Fate, Effects, and Risks of Dexamethasone: Ecological Implications Post-COVID-19.
    Musee N; Kebaabetswe LP; Tichapondwa S; Tubatsi G; Mahaye N; Leareng SK; Nomngongo PN
    Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms and treatment responses of pulmonary fibrosis in severe COVID-19.
    Kooistra EJ; Dahm K; van Herwaarden AE; Gerretsen J; Nuesch Germano M; Mauer K; Smeets RL; van der Velde S; van den Berg MJW; van der Hoeven JG; Aschenbrenner AC; Schultze JL; Ulas T; Kox M; Pickkers P
    Respir Res; 2023 Aug; 24(1):196. PubMed ID: 37559053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19.
    Hong JY; Ko JH; Yang J; Ha S; Nham E; Huh K; Cho SY; Kang CI; Chung DR; Baek JY; Sohn YM; Park HJ; Lee B; Huh HJ; Kang ES; Suh GY; Chung CR; Peck KR
    Yonsei Med J; 2022 May; 63(5):430-439. PubMed ID: 35512745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients.
    Saeed MAM; Mohamed AH; Owaynat AH
    Egypt J Intern Med; 2022; 34(1):19. PubMed ID: 35194371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study.
    Mühlemann B; Thibeault C; Hillus D; Helbig ET; Lippert LJ; Tober-Lau P; Schwarz T; Müller MA; ; Witzenrath M; Suttorp N; Sander LE; Drosten C; Jones TC; Corman VM; Kurth F
    Clin Microbiol Infect; 2021 Oct; 27(10):1520.e7-1520.e10. PubMed ID: 34139335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?
    Kino T; Burd I; Segars JH
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecological and toxicological effects of inorganic nitrogen pollution in aquatic ecosystems: A global assessment.
    Camargo JA; Alonso A
    Environ Int; 2006 Aug; 32(6):831-49. PubMed ID: 16781774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sources, pathways, and relative risks of contaminants in surface water and groundwater: a perspective prepared for the Walkerton inquiry.
    Ritter L; Solomon K; Sibley P; Hall K; Keen P; Mattu G; Linton B
    J Toxicol Environ Health A; 2002 Jan; 65(1):1-142. PubMed ID: 11809004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current understanding of potential ecological risks of retinoic acids and their metabolites in aquatic environments.
    Yeung KWY; Zhou GJ; Hilscherová K; Giesy JP; Leung KMY
    Environ Int; 2020 Mar; 136():105464. PubMed ID: 31926435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence, bioaccumulation and toxicological effect of drugs of abuse in aquatic ecosystem: A review.
    Chen L; Guo C; Sun Z; Xu J
    Environ Res; 2021 Sep; 200():111362. PubMed ID: 34048744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation.
    De Pascale G; Cutuli SL; Carelli S; Xhemalaj R; Rosà T; Bello G; Vargas J; Cesarano M; Montini L; Tanzarella ES; Pintaudi G; Di Muro M; Grieco DL; Antonelli M
    PLoS One; 2022; 17(4):e0267038. PubMed ID: 35482703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insights on Effects of Glucocorticoids in Patients With SARS-CoV-2 Infection.
    Shacham EC; Ishay A
    Endocr Pract; 2022 Oct; 28(10):1100-1106. PubMed ID: 35870803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting and assessing the toxicity and ecological risk of seven widely used neonicotinoid insecticides and their aerobic transformation products to aquatic organisms.
    Shen C; Pan X; Wu X; Xu J; Dong F; Zheng Y
    Sci Total Environ; 2022 Nov; 847():157670. PubMed ID: 35908706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential therapeutic use of corticosteroids as SARS CoV-2 main protease inhibitors: a computational study.
    Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
    J Biomol Struct Dyn; 2022 Mar; 40(5):2053-2066. PubMed ID: 33094701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide combined with short-term low-dose glucocorticoid therapy for the treatment of severe COVID-19: A case-series study.
    Li Y; Shi K; Qi F; Yu Z; Chen C; Pan J; Wu G; Chen Y; Li J; Chen Y; Zhou T; Li X; Xia J
    Int J Infect Dis; 2021 Feb; 103():507-513. PubMed ID: 33333254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role and place of pathogenetic therapy with glucocorticosteroid hormones in the treatment of patients with novel coronavirus infection (COVID-19)].
    Efremov DO; Beloborodov VB
    Ter Arkh; 2021 Nov; 93(11):1395-1400. PubMed ID: 36286665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study.
    Stanevich OV; Fomina DS; Bakulin IG; Galeev SI; Bakin EA; Belash VA; Kulikov AN; Lebedeva AA; Lioznov DA; Polushin YS; Shlyk IV; Vorobyev EA; Vorobyeva SV; Surovceva TV; Bakulina NV; Lysenko MA; Moiseev IS
    BMC Infect Dis; 2021 Dec; 21(1):1277. PubMed ID: 34937556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone for COVID-19? Not so fast.
    Theoharides TC; Conti P
    J Biol Regul Homeost Agents; 2020 Jul-Aug,; 34(3):1241-1243. PubMed ID: 32551464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone for treating SARS-CoV-2 infection: a systematic review and meta-analysis.
    Ferreto LED; Bortoloti DS; Fortes PCN; Follador F; Arruda G; Ximenez JP; Wendt GW
    Sao Paulo Med J; 2021; 139(6):657-661. PubMed ID: 34644768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.